Ahmed Noaman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed Noaman has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Usama Ragab
Internal Medicine Department, Faculty of Medicine, Zagazig University, Egypt
2 shared publications - Ahmed Abdulsaboor
Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication Fady Atalah Labib
Internal Medicine Department, Beala Central Hospital, Kafr Elshiekh, Egypt
1 shared publication- Ghada Amr
Zagazig University Faculty of Medicine, Clinical Pathology, 10 Elfardos Street, Hai Elsalam, Zagazig, Egypt
1 shared publication - Mahmoud Mohamed Kamel
Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
1 shared publication Sameh Hussein Abdel-Hamid
Al-Ahrar Teaching Hospital, Zagazig, Egypt
1 shared publication
Latest Publications
- 19 March 2023
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Clinical Features of COVID-19 Hospitalized Patients with different degree of Proteinuria
Background: Coronavirus disease-19 (COVID-19) is a lung disease that also negatively affects several organ systems. Patients with COVID-19 frequently have kidney dysfunction. The exact impact of proteinuria and its degree on the clinical outcome of patients with COVID-19 is unclear. Objective: This study aimed to assess the effect of different degrees of proteinuria on the clinical outcome of hospitalized patients with COVID-19. Patients and methods: This study included 100 patients with COVID-19 at Isolation Department, Zagazig University and Al-Ahrar Teaching Hospitals who presented with proteinuria on admission. Patients were divided into two groups based on their urine protein creatinine ratio (UPCR): those with UPCR less than 1gm and those with UPCR greater than 1gm. Results: There is a statistically significant relation between the two groups regarding neutrophil count (p=0.027) (higher in patients with UPCR > 1gm), and lymphocytes (p=0.003) (lower in patients with UPCR > 1gm). There is a statically significant relation between the degree of proteinuria and the incidence of acute kidney injury (p1gm). Conclusion: Proteinuria in COVID-19 hospitalized patients is associated with poor clinical outcomes and could lead to further renal deterioration and AKI, so it is important to screen for it.
- 19 March 2023
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Clinical Features of COVID-19 Hospitalized Patients with different degree of Proteinuria
Background: Coronavirus disease-19 (COVID-19) is a lung disease that also negatively affects several organ systems. Patients with COVID-19 frequently have kidney dysfunction. The exact impact of proteinuria and its degree on the clinical outcome of patients with COVID-19 is unclear. Objective: This study aimed to assess the effect of different degrees of proteinuria on the clinical outcome of hospitalized patients with COVID-19. Patients and methods: This study included 100 patients with COVID-19 at Isolation Department, Zagazig University and Al-Ahrar Teaching Hospitals who presented with proteinuria on admission. Patients were divided into two groups based on their urine protein creatinine ratio (UPCR): those with UPCR less than 1gm and those with UPCR greater than 1gm. Results: There is a statistically significant relation between the two groups regarding neutrophil count (p=0.027) (higher in patients with UPCR > 1gm), and lymphocytes (p=0.003) (lower in patients with UPCR > 1gm). There is a statically significant relation between the degree of proteinuria and the incidence of acute kidney injury (p1gm). Conclusion: Proteinuria in COVID-19 hospitalized patients is associated with poor clinical outcomes and could lead to further renal deterioration and AKI, so it is important to screen for it.
- 14 March 2023
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Study of Urinary Angiotensinogen as an Indicator of Severity of Diabetic Nephropathy in Type 2 Diabetes
Background: Urinary angiotensinogen levels are higher in type 2 diabetes patients with nephropathy, a risk factor for developing renal and cardiovascular consequences. However, the potential relationship between serum urine angiotensinogen levels and albuminuria (in terms of its varying concentrations) is not yet established. As a result, we conduct this research. Method: Sixty-six adults with type 2 diabetes were split into three groups, each of which included 22 people based on their degree of albuminuria, in addition to an age- and gender-matched control group of 22 healthy volunteers. Routine laboratory tests and urine angiotensinogen were evaluated in the study groups and correlated to other study parameters. Results: The current study showed that urine angiotensinogen levels are more significant in diabetic patients with higher albuminuria levels, and it was also found to be associated with urinary albumin excretion in diabetic patients with different grades of albuminuria (n = 66, r = 0.666, p<0.001), and it had highly significant validity in the prediction of albuminuria among individuals with diabetes with sensitivity of 88.6%, specificity of 81.8% and accuracy of 86.4%. Conclusions: According to the findings of this study, increased urine angiotensinogen levels were associated with urinary albumin excretion, and elevated urinary angiotensinogen might be utilized as an effective marker for identifying the degree of albuminuria in diabetic individuals.
- 14 March 2023
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Study of Urinary Angiotensinogen as an Indicator of Severity of Diabetic Nephropathy in Type 2 Diabetes
Background: Urinary angiotensinogen levels are higher in type 2 diabetes patients with nephropathy, a risk factor for developing renal and cardiovascular consequences. However, the potential relationship between serum urine angiotensinogen levels and albuminuria (in terms of its varying concentrations) is not yet established. As a result, we conduct this research. Method: Sixty-six adults with type 2 diabetes were split into three groups, each of which included 22 people based on their degree of albuminuria, in addition to an age- and gender-matched control group of 22 healthy volunteers. Routine laboratory tests and urine angiotensinogen were evaluated in the study groups and correlated to other study parameters. Results: The current study showed that urine angiotensinogen levels are more significant in diabetic patients with higher albuminuria levels, and it was also found to be associated with urinary albumin excretion in diabetic patients with different grades of albuminuria (n = 66, r = 0.666, p<0.001), and it had highly significant validity in the prediction of albuminuria among individuals with diabetes with sensitivity of 88.6%, specificity of 81.8% and accuracy of 86.4%. Conclusions: According to the findings of this study, increased urine angiotensinogen levels were associated with urinary albumin excretion, and elevated urinary angiotensinogen might be utilized as an effective marker for identifying the degree of albuminuria in diabetic individuals.